The liquid-to-solid transition of FUS is promoted by the condensate surface.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
15 08 2023
Historique:
pmc-release: 07 02 2024
medline: 9 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

A wide range of macromolecules can undergo phase separation, forming biomolecular condensates in living cells. These membraneless organelles are typically highly dynamic, formed reversibly, and carry out essential functions in biological systems. Crucially, however, a further liquid-to-solid transition of the condensates can lead to irreversible pathological aggregation and cellular dysfunction associated with the onset and development of neurodegenerative diseases. Despite the importance of this liquid-to-solid transition of proteins, the mechanism by which it is initiated in normally functional condensates is unknown. Here we show, by measuring the changes in structure, dynamics, and mechanics in time and space, that single-component FUS condensates do not uniformly convert to a solid gel, but rather that liquid and gel phases coexist simultaneously within the same condensate, resulting in highly inhomogeneous structures. Furthermore, our results show that this transition originates at the interface between the condensate and the dilute continuous phase, and once initiated, the gelation process propagates toward the center of the condensate. To probe such spatially inhomogeneous rheology during condensate aging, we use a combination of established micropipette aspiration experiments together with two optical techniques, spatial dynamic mapping and reflective confocal dynamic speckle microscopy. These results reveal the importance of the spatiotemporal dimension of the liquid-to-solid transition and highlight the interface of biomolecular condensates as a critical element in driving pathological protein aggregation.

Identifiants

pubmed: 37549257
doi: 10.1073/pnas.2301366120
pmc: PMC10438845
doi:

Substances chimiques

FUS protein, human 0
RNA-Binding Protein FUS 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2301366120

Subventions

Organisme : Wellcome Trust
ID : 203249/Z/16/Z
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U01 AG072572
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG070864
Pays : United States

Références

Cell. 2015 Aug 27;162(5):1066-77
pubmed: 26317470
DNA Repair (Amst). 2021 Oct;106:103179
pubmed: 34311273
EMBO J. 2018 Apr 3;37(7):
pubmed: 29472250
Sci Rep. 2016 Aug 08;6:31155
pubmed: 27499269
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2119800119
pubmed: 35727989
Nat Commun. 2015 Jul 28;6:7831
pubmed: 26215704
J Mol Biol. 2023 Jan 15;435(1):167713
pubmed: 35787838
Cell. 2015 Sep 24;163(1):123-33
pubmed: 26406374
Cell. 2018 Apr 19;173(3):720-734.e15
pubmed: 29677515
Annu Rev Cell Dev Biol. 2014;30:39-58
pubmed: 25288112
Nat Commun. 2022 Dec 13;13(1):7722
pubmed: 36513655
J Neurosci. 1996 Dec 15;16(24):7812-20
pubmed: 8987809
Science. 2020 Dec 11;370(6522):1317-1323
pubmed: 33303613
Neuron. 2015 Nov 18;88(4):678-90
pubmed: 26526393
J Mater Chem B. 2016 Dec 28;4(48):7989-7999
pubmed: 32263788
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7189-94
pubmed: 26015579
Nat Commun. 2022 May 31;13(1):3030
pubmed: 35641495
Nat Nanotechnol. 2020 Oct;15(10):841-847
pubmed: 32661370
Biophys Rep (N Y). 2021 Sep 8;1(1):
pubmed: 36247368
Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2202240119
pubmed: 36067308
Nat Commun. 2020 Jun 4;11(1):2809
pubmed: 32499559
Nat Commun. 2021 Feb 17;12(1):1085
pubmed: 33597515
Science. 2009 Jun 26;324(5935):1729-32
pubmed: 19460965
J Biol Chem. 2019 Apr 19;294(16):6306-6317
pubmed: 30814253
Molecules. 2020 Oct 15;25(20):
pubmed: 33076213
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2109718119
pubmed: 35901206
Science. 2019 Mar 8;363(6431):1093-1097
pubmed: 30846599
Nat Chem. 2020 Aug;12(8):705-716
pubmed: 32514159
Nat Commun. 2021 Jan 29;12(1):688
pubmed: 33514697
Nat Commun. 2020 Jun 10;11(1):2945
pubmed: 32522983
Phys Rev Lett. 2008 May 9;100(18):188102
pubmed: 18518417

Auteurs

Yi Shen (Y)

Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia.
The University of Sydney Nano Institute, The University of Sydney, Sydney, NSW 2006, Australia.

Anqi Chen (A)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Wenyun Wang (W)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Yinan Shen (Y)

Department of Physics, Harvard University, Cambridge, MA 02138.

Francesco Simone Ruggeri (FS)

Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Laboratory of Organic Chemistry, Wageningen University, 6708 WE Wageningen, the Netherlands.
Physical Chemistry and Soft Matter, Wageningen University, 6708 WE Wageningen, the Netherlands.

Stefano Aime (S)

Molecular, Macromolecular Chemistry, and Materials, École Supérieure de Physique et de Chimie Industrielles Paris, CNRS, Paris Sciences & Lettres University, Paris 75005, France.

Zizhao Wang (Z)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Seema Qamar (S)

Cambridge Institute for Medical Research, Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0XY, United Kingdom.

Jorge R Espinosa (JR)

Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom.

Adiran Garaizar (A)

Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom.

Peter St George-Hyslop (P)

Cambridge Institute for Medical Research, Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0XY, United Kingdom.
Department of Medicine (Neurology), Tanz Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5T 0S8, Canada.
University Health Network, Toronto, ON M5T 0S8, Canada.
Taub Institute For Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Irvine Medical Center, New York, NY 10032.

Rosana Collepardo-Guevara (R)

Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom.
Department of Genetics, University of Cambridge, Cambridge CB2 3EH, United Kingdom.

David A Weitz (DA)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
Department of Physics, Harvard University, Cambridge, MA 02138.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Daniele Vigolo (D)

The University of Sydney Nano Institute, The University of Sydney, Sydney, NSW 2006, Australia.
School of Biomedical Engineering, The University of Sydney, Sydney, NSW 2006, Australia.

Tuomas P J Knowles (TPJ)

Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH